DRTECH Corporation Net Assets
DRTECH Corporation net assets. Based on the latest financial reports, DRTECH Corporation (214680) has net assets worth ₩84.82 Billion KRW (≈ $57.48 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩235.84 Billion ≈ $159.82 Million USD) and total liabilities (₩151.02 Billion ≈ $102.34 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore DRTECH Corporation (214680) net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩84.82 Billion |
| % of Total Assets | 35.96% |
| Annual Growth Rate | 12.17% |
| 5-Year Change | 74.02% |
| 10-Year Change | N/A |
| Growth Volatility | 19.46 |
Net Assets of DRTECH Corporation (2016–2025)
Net assets of DRTECH Corporation from 2016 to 2025. This chart illustrates how DRTECH Corporation's net assets have evolved over time, based on quarterly financial data. See DRTECH Corporation net asset quality index to measure how much of total assets are equity-financed.
Annual Net Assets for DRTECH Corporation (2016–2025)
The table below shows the annual net assets of DRTECH Corporation from 2016 to 2025. For live market cap and overall valuation, see 214680 company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩76.77 Billion ≈ $52.02 Million |
+5.49% |
| 2024-12-31 | ₩72.77 Billion ≈ $49.32 Million |
-13.97% |
| 2023-12-31 | ₩84.59 Billion ≈ $57.33 Million |
+40.11% |
| 2022-12-31 | ₩60.38 Billion ≈ $40.92 Million |
+36.86% |
| 2021-12-31 | ₩44.11 Billion ≈ $29.90 Million |
+33.28% |
| 2020-12-31 | ₩33.10 Billion ≈ $22.43 Million |
-11.41% |
| 2019-12-31 | ₩37.36 Billion ≈ $25.32 Million |
+19.25% |
| 2018-12-31 | ₩31.33 Billion ≈ $21.23 Million |
+18.20% |
| 2017-12-31 | ₩26.50 Billion ≈ $17.96 Million |
-2.91% |
| 2016-12-31 | ₩27.30 Billion ≈ $18.50 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to DRTECH Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1098.9% over the analyzed period, potentially due to dividend distributions or operating losses.
DRTECH Corporation Net Assets Breakdown (December 2025)
DRTECH Corporation net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩120.63 Billion | 157.20% |
| Total Equity | ₩76.74 Billion | 100.00% |
DRTECH Corporation Competitors by Market Cap
The table below lists competitors of DRTECH Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Müller - Die lila Logistik AG
XETRA:MLL
|
$35.72 Million |
|
Panjawattana Plastic Public Company Limited
BK:PJW
|
$35.74 Million |
|
Innometry Co. Ltd
KQ:302430
|
$35.76 Million |
|
Development Advance Solution Co Ltd
KO:058730
|
$35.77 Million |
|
KCI Limited
KQ:036670
|
$35.69 Million |
|
Taylor Wimpey PLC
LSE:TW
|
$35.68 Million |
|
Simonds Group Ltd
AU:SIO
|
$35.65 Million |
|
LiveOne Inc
NASDAQ:LVO
|
$35.65 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DRTECH Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 72,773,225,510 to 76,739,760,800, a change of 3,966,535,290 (5.5%).
- Net loss of 24,027,325,210 reduced equity.
- New share issuances of 15,089,639,870 increased equity.
- Other factors increased equity by 12,904,220,630.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-24.03 Billion | -31.31% |
| Share Issuances | ₩15.09 Billion | +19.66% |
| Other Changes | ₩12.90 Billion | +16.82% |
| Total Change | ₩- | 5.45% |
Book Value vs Market Value Analysis
This analysis compares DRTECH Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.43x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 4.65x to 3.43x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩677.92 | ₩3155.00 | x |
| 2017-12-31 | ₩641.33 | ₩3155.00 | x |
| 2018-12-31 | ₩708.62 | ₩3155.00 | x |
| 2019-12-31 | ₩762.81 | ₩3155.00 | x |
| 2020-12-31 | ₩639.17 | ₩3155.00 | x |
| 2021-12-31 | ₩779.06 | ₩3155.00 | x |
| 2022-12-31 | ₩1040.60 | ₩3155.00 | x |
| 2023-12-31 | ₩1168.24 | ₩3155.00 | x |
| 2024-12-31 | ₩983.22 | ₩3155.00 | x |
| 2025-12-31 | ₩919.29 | ₩3155.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DRTECH Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -31.31%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -20.66%
- • Asset Turnover: 0.58x
- • Equity Multiplier: 2.63x
- Recent ROE (-31.31%) is below the historical average (-6.52%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -1.60% | -1.19% | 0.97x | 1.38x | ₩-3.17 Billion |
| 2017 | -6.85% | -4.68% | 0.89x | 1.64x | ₩-4.47 Billion |
| 2018 | 3.98% | 2.79% | 0.90x | 1.59x | ₩-1.89 Billion |
| 2019 | 2.53% | 1.97% | 0.67x | 1.90x | ₩-2.79 Billion |
| 2020 | -21.85% | -13.08% | 0.60x | 2.77x | ₩-10.54 Billion |
| 2021 | 9.15% | 5.75% | 0.75x | 2.13x | ₩-373.34 Million |
| 2022 | 9.89% | 6.67% | 0.74x | 2.00x | ₩-65.46 Million |
| 2023 | -2.66% | -2.43% | 0.56x | 1.94x | ₩-10.71 Billion |
| 2024 | -26.51% | -19.77% | 0.54x | 2.46x | ₩-26.57 Billion |
| 2025 | -31.31% | -20.66% | 0.58x | 2.63x | ₩-31.70 Billion |
Industry Comparison
This section compares DRTECH Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $331,616,884,658
- Average return on equity (ROE) among peers: 2.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DRTECH Corporation (214680) | ₩84.82 Billion | -1.60% | 1.78x | $35.70 Million |
| Shinhung (004080) | $82.95 Billion | 8.13% | 0.49x | $91.99 Million |
| HansBiomed Corporation (042520) | $65.30 Billion | 6.15% | 0.41x | $140.38 Million |
| JVM Co. Ltd (054950) | $158.12 Billion | 9.96% | 0.47x | $191.63 Million |
| U&I Corporation (056090) | $59.07 Billion | -3.52% | 0.12x | $304.75 Million |
| Huvitz Co. Ltd (065510) | $83.90 Billion | 8.45% | 0.69x | $45.48 Million |
| Vieworks Co. Ltd (100120) | $248.67 Billion | 8.84% | 0.42x | $179.05 Million |
| Corentec Co Ltd (104540) | $24.09 Billion | -123.57% | 1.67x | $43.15 Million |
| SD Biosensor Inc (137310) | $2.20 Trillion | 48.32% | 0.36x | $524.49 Million |
| Hironic Co. Ltd (149980) | $43.93 Billion | 6.45% | 0.04x | $41.40 Million |
| Humasis Co. Ltd (205470) | $346.73 Billion | 52.67% | 0.35x | $171.77 Million |
About DRTECH Corporation
DRTECH Corporation develops and sells flat-panel X-ray detectors for digital radiography in South Korea and internationally. Its products include detectors for general radiography, mammography, dynamic, dental, veterinary, and industrial applications; imaging solutions, including specialized UI software, dual energy x-ray imaging, AI imaging processing, advanced image reconstruction technology, a… Read more